secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beyond Air, Inc. (XAIR)
CIK:        0001641631
Form:       8-K
Filed at:   2024-02-16T23:59:59+00:00
Accession:  0001493152-24-007013
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beyond Air Q3 FY2024 net loss $16.2M; revenues $0.4M; FY2025 guidance reiterated $12-16M
--------------------------------------------------------------------------------

- Net loss $16.2M ($0.50 per share) vs $12.7M ($0.43) in Q3 FY2023; revenues $0.4M from zero prior year.
- FY2025 revenue guidance reiterated at $12M-$16M; LungFit PH filter shipments up >100% QoQ.
- PMA supplement for cardiac surgery label expansion accepted for filing and under FDA substantive review.
- Cash, marketable securities $31.4M as of Dec 31, 2023; raised $5.5M via ATM to offset burn.
- CMO Dr. Myers transitions to consultant effective Feb 16; CCO Duncan Fatkin leaves March 31.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641631/000149315224007013/0001493152-24-007013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641631/000149315224007013/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-007013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer